ROTABLATOR(R)
Boston Scientific Corp · Decision date May 28, 1993
What did the FDA approve?
FDA records P900056 as an original PMA application. The recorded decision is approval, dated May 28, 1993.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- May 28, 1993
Regulatory record facts
- Identifier
- P900056
- Regulatory pathway
- Premarket approval application
- Applicant
- Boston Scientific Corp
- Product code
- MCX
- Decision code
- APPR
- Decision date
- May 28, 1993
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: CATHETER, CORONARY, ATHERECTOMY.
- Applicant
- Boston Scientific Corp
- Product code
- MCX
- FDA device class
- 3
FDA decision timeline
P900056 received
Application receipt date recorded by FDA.
P900056 · FDA decision
APPR
P900056/S228 · Related supplement
ROTAPRO Rotational Atherectomy System
P900056/S226 · Related supplement
ROTAPRO Rotational Atherectomy Systems
P900056/S229 · Related supplement
ROTAPRO Rotational Atherectomy System
Timeline entries are records held by MedtechLedger for P900056. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P900056
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ROTAPRO Rotational Atherectomy SystemP900056/S228 | Boston Scientific Corp | PMA supplement | Oct 20, 2026 | FDA |
ROTAPRO Rotational Atherectomy SystemsP900056/S226 | Boston Scientific Corp | PMA supplement | Oct 21, 2026 | FDA |
ROTAPRO Rotational Atherectomy SystemP900056/S229 | Boston Scientific Corp | PMA supplement | Oct 21, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- Two Scimed Pl., Maple Grove, MN, 55311
Sources and methodology
- Original FDA record: P900056
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

